Apheresis Market Report
First published: 07 October 2024 | Last updated: 22 April 2026 | Report Code: apheresis
Apheresis Market — USD 2.5 billion in 2023, Growing to USD 4.91B by 2033 at 6.8% CAGR
This report provides comprehensive insights into the apheresis market from 2023 to 2033, including industry trends, market size, segmentation, and forecasts. It aims to equip stakeholders with the necessary data for informed decision-making.
Key Takeaways
- Global market valued at $2.50 Billion in 2023 and expected to reach $4.91 Billion by 2033 at a 6.8% CAGR.
- North America is both the largest and the fastest-growing region, reflecting strong clinical adoption and investment.
- Technological innovation and rising therapeutic apheresis demand are key contributors to market expansion.
- Leading participants include Fresenius Kabi, Terumo BCT, Haemonetics Corporation, and Cerus Corporation.
- Regional rollouts and growing awareness of apheresis applications will support sustained equipment and consumables demand.
Apheresis Market Report — Executive Summary
The apheresis market demonstrates steady expansion driven by clinical demand and device innovation. Valued at $2.50 Billion in 2023 and forecast to reach $4.91 Billion by 2033 at a 6.8% CAGR, the market is propelled by advances in automated systems, broader therapeutic applications, and increasing donor procedures. North America leads the market in both size and growth, supported by established healthcare infrastructure and early adoption of novel devices. Key vendors such as Fresenius Kabi, Terumo BCT, Haemonetics Corporation, and Cerus Corporation are investing in product development and partnerships to enhance throughput and safety. Market segmentation spans devices, consumables, end-users like hospitals and blood banks, and applications including therapeutic and donor apheresis. Stakeholders should prioritize regulatory alignment, device maintenance strategies, and training to capitalize on demand from chronic disease management and personalized treatment protocols. Regional differences in uptake highlight opportunities for targeted investments and commercialization approaches through 2023 to 2033.
Key Growth Drivers
- Rising prevalence of chronic and autoimmune conditions increasing demand for therapeutic apheresis procedures.
- Technological improvements in automated apheresis devices enhancing clinical efficiency and patient safety.
- Greater awareness and use of donor apheresis for platelets and plasma expanding collection volumes.
- Investment by leading companies in R&D and partnerships to broaden product portfolios and geographic reach.
- Strengthening healthcare infrastructure and reimbursement frameworks in major markets supporting adoption.
| Metric | Value |
|---|---|
| Study Period | 2023 - 2033 |
| 2023 Market Size | $2.50 Billion |
| CAGR (2023-2033) | 6.8% |
| 2033 Market Size | $4.91 Billion |
| Top Companies | Fresenius Kabi, Terumo BCT, Haemonetics Corporation, Cerus Corporation |
| Published Date | 07 October 2024 |
| Last Modified Date | 22 April 2026 |
Apheresis Market Overview
Customize Apheresis Market Report market research report
- ✔ Get in-depth analysis of Apheresis market size, growth, and forecasts.
- ✔ Understand Apheresis's regional dynamics and industry-specific trends.
- ✔ Identify potential applications, end-user demand, and growth segments in Apheresis
What is the Market Size & CAGR of Apheresis Market Report market in 2023?
Apheresis Industry Analysis
Apheresis Market Segmentation and Scope
Tell us your focus area and get a customized research report.
Apheresis Market Report Market Analysis Report by Region
Europe Apheresis Market Report:
Europe is forecast to expand from $0.7 Billion in 2023 to $1.38 Billion in 2033. Growth reflects increasing clinical uptake, regulatory support for advanced therapies, and growing use of apheresis in both therapeutic and donation settings.Asia Pacific Apheresis Market Report:
Asia Pacific is expected to grow from $0.49 Billion in 2023 to $0.97 Billion in 2033. Expansion is supported by improving healthcare access, rising awareness of apheresis applications, and investments in medical technology across key markets.North America Apheresis Market Report:
North America is identified as the largest and fastest-growing region, with market value moving from $0.82 Billion in 2023 to $1.61 Billion in 2033. Local growth is driven by advanced clinical infrastructure, rapid technology adoption, and strong presence of major suppliers.South America Apheresis Market Report:
Middle East & Africa Apheresis Market Report:
The Middle East and Africa region is set to grow from $0.35 Billion in 2023 to $0.69 Billion in 2033. Growth drivers include expanding healthcare capacity, targeted investments, and rising demand for advanced apheresis procedures.Tell us your focus area and get a customized research report.
Research Methodology
Apheresis Market Analysis By Product
In the product segment, blood collection sets dominate the market, valued at $1.61 billion in 2023, with a projection to reach $3.16 billion by 2033, accounting for around 64.22% market share. Apheresis devices will see significant growth from $0.52 billion in 2023 to $1.03 billion in 2033, holding 20.94% share, while consumables are expected to double to $0.73 billion by 2033.
Apheresis Market Analysis By Application
Therapeutic apheresis is the largest segment, estimated at $2.17 billion in 2023 and projected to grow to $4.27 billion by 2033, maintaining a dominant share of 86.96%. Donor apheresis accounts for a smaller share, forecasted to rise from $0.33 billion to $0.64 billion over the same period.
Apheresis Market Analysis By End User
Hospitals lead in end-user applications, currently valued at $1.61 billion in 2023 and expected to hit $3.16 billion by 2033. Blood banks and research centers, while smaller markets at $0.52 billion and $0.37 billion respectively in 2023, will also show promising growth.
Apheresis Market Analysis By Region
The regional analysis confirms North America as the largest market with ongoing innovations, followed by Europe and Asia-Pacific as rapidly growing regions due to improvements in healthcare and rising disease prevalence, while South America and the Middle East/Africa present emerging opportunities for market penetration.
Apheresis Market Trends and Future Forecast
Tell us your focus area and get a customized research report.
Global Market Leaders and Top Companies in Apheresis Industry
Fresenius Kabi:
A leading provider of apheresis products and services, Fresenius Kabi focuses on innovative solutions for blood and cell therapy.Terumo BCT:
Terumo specializes in blood collection and processing systems, with a strong emphasis on apheresis technologies to enhance patient care.Haemonetics Corporation:
Identified as a global leader in blood management solutions, their advanced apheresis devices improve donor safety and therapeutic outcomes.Cerus Corporation:
Cerus is known for its innovative INTERCEPT Blood System, enhancing blood safety and optimizing apheresis procedures across the globe.We're grateful to work with incredible clients.
FAQs
What is the market size of the apheresis market?
The market size was $2.50 Billion in 2023 and is projected to reach $4.91 Billion by 2033, reflecting a forecast period of 2023 to 2033 and a compound annual growth rate of 6.8%.
How big is the market expected to be by 2033?
By 2033 the market is expected to be $4.91 Billion according to the provided forecast, up from $2.50 Billion in 2023, based on the stated 6.8% CAGR for 2023 to 2033.
Why is North America significant in this market?
North America is both the largest and fastest-growing region, supported by established clinical infrastructure, adoption of advanced apheresis systems, and concentrated activity by major suppliers and research centers.
Which companies are listed as top players?
Top companies identified include Fresenius Kabi, Terumo BCT, Haemonetics Corporation, and Cerus Corporation, which are noted for product development and market presence across key regions.
Who are the primary end users of apheresis products?
Primary end users include hospitals, blood banks, and research centers, which utilize devices and consumables for both therapeutic and donor apheresis procedures.
What is CAGR for the forecast period?
The compound annual growth rate for the forecast period 2023 to 2033 is 6.8%, as provided in the market data accompanying the report.
How does regional growth vary globally?
Regional growth shows North America leading in both size and pace, while Europe, Asia Pacific, Latin America, and Middle East and Africa exhibit varying adoption rates tied to infrastructure and investment levels.
What are the main application segments?
Key application segments are therapeutic apheresis and donor apheresis, covering clinical treatment protocols and blood component collection activities in clinical and donation settings.
What product types are included in the market?
Product categories encompass apheresis devices, blood collection sets, and other consumables, supporting procedural workflows across hospitals and blood collection centers.
How was the market analysis conducted?
The analysis is based on primary interviews with industry experts and secondary research from company reports and publications, supported by data triangulation and expert validation.